A full 14 years after founding CRO Clinipace, its long-standing CEO and president, Jeff Williams, is planning to step down.
WuXi AppTec buys U.S.-based full-service CRO ResearchPoint Global, tapping the latter's clinical operations in over 60 countries.
South Korean, Celltrion group is a global leader for biologic medicine and is a pioneer in the approval of biosimilar profile in Europe, US and Brazil. The…
Janssen has developed a mobile toolkit for trial supply management and patient engagement that can track adherence to each pill.
OmniComm signed its seventh client in China that uses its phase 1 EDC system TrialOne.
Brought to you by the publisher of FierceBiotech and FiercePharma, the Fierce Innovation Awards Life Sciences Edition identify and showcase outstanding…
It can be seriously disruptive when the site investigator for your trial leaves or decides to step down, but new recommendations from the Clinical Trials…
Elligo Health Research will test a harmonized real-word data model built by the FDA.
As part of our video series for this year’s DDF 2017 event, life science leaders spoke to us about CRO needs and new regulations.
SynteractHCR has seen another change-up as it moves its headquarters to larger digs.
PPD has taken on a former FDA veteran, Jonca Bull, M.D., as its new VP of PPD consulting and ophthalmology within global product development.
U.K.-based trial services company Ergomed has penned a deal to buy PSR Group BV, a specialist orphan drug CRO, as it adds to its offerings.